Blancco Diagnostics (India) Private Limited - Company Profile

It is a information technology private limited company based in Pune, Maharashtra, India, established in 2016.
2016 Pune, Maharashtra, India Active
Last Updated:
Access Report
About Blancco Diagnostics (India) Private Limited

Blancco Diagnostics (India) Private Limited, a active private limited company, was established on 21 April 2016 in Pune, Maharashtra, India. Engaging in it consulting & support services within the information and communication sector, it holds CIN: U74999PN2016PTC164058. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹10.00 K .

It upholds a compliant status. Employing 65 professional, Its leadership includes Satoru Johan Ogawa (Director), Sourabh Sodani (Additional Director). Past directors included Jog Dhody, Matias Leandro Toye Iglesias, Jaslieen Kaur Baghh. It holds ₹0.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sairadhe Complex,B Wing,Ofc No.109,Urbanwrk Floor5 Sangamwadi, Kennedy Rd, Bhd Hotel Sherat, On Grand, Pune, Maharashtra, 411001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999PN2016PTC164058

  • Registration Number

    164058

  • Incorporation Date

    21 April 2016

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹10.00 K

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 10.00 K
  • Company Age 9 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 0.50 M
  • Revenue Growth **** 10.82%
  • Profit Growth **** 17.93%
  • Ebitda **** 83.57%
  • Net Worth 20.88%
  • Total Assets **** 19.00%
Company report

Blancco Diagnostics (India) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Blancco Diagnostics (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Blancco Diagnostics (India) Private Limited?
Current Directors
Name Designation Appointment Date Status
Satoru Johan Ogawa Director 03 May 2024 Current
Sourabh Sodani Additional Director 07 Mar 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 17 Mar 2017 Past
Pramod Abcsdd Director 08 Mar 2018 Past
Pramod Abcsdd Additional Director 29 Dec 2017 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Additional Director 17 Mar 2017 Past
Pramod Abcsdd Additional Director 30 Oct 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Blancco Diagnostics (India).

Blancco Diagnostics (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.82% increase. The company also saw a substantial improvement in profitability, with a 17.93% increase in profit. The company's net worth Soared by an impressive increase of 20.88%.

Blancco Diagnostics (India) revenue growth over time
Blancco Diagnostics (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 10.82%
*******
*******
*******
*******
Revenue from Operations
*******
 18.33%
*******
*******
*******
*******
Total Assets
*******
 19.00%
*******
*******
*******
*******
Profit or Loss
*******
 17.93%
*******
*******
*******
*******
Net Worth
*******
 20.88%
*******
*******
*******
*******
EBITDA
*******
 83.57%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Blancco Diagnostics (India)?

In 2023, Blancco Diagnostics (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹500,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • The Hongkong And Shanghai Banking Corporation Limited : 0.05 Cr
Latest Charge Details
Date Lender Amount Status
16 Feb 2024 The Hongkong And Shanghai Banking Corporation Limited ₹0.50 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Blancco Diagnostics (India)?

Blancco Diagnostics (India) has a workforce of 65 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Blancco Diagnostics (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blancco Diagnostics (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Blancco Diagnostics (India)
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Blancco Diagnostics (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Blancco Diagnostics (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was recorded as a recent event.

  • Director Appointment

    Sourabh Sodani was appointed as a Additional Director was appointed as a Additional Director on 07 Mar 2025 & has been associated with this company since 11 months 20 days . was recorded as a recent event.

  • Director Appointment

    The activity Satoru Johan Ogawa was appointed as a Director was appointed as a Director on 03 May 2024 & has been associated with this company since 1 year 9 months . was completed.

  • Charges

    The activity A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 0.50 M with Charge ID 100890229 was registered on 16 Feb 2024. was completed.

  • Company Incorporation

    Blancco Diagnostics (India) Private Limited was registered on 21 Apr 2016 with Roc Pune & aged 9 years 10 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Blancco Diagnostics (India) Private Limited?

The CIN of Blancco Diagnostics (India) Private Limited is U74999PN2016PTC164058.

Where is Blancco Diagnostics (India) Private Limited headquartered?

Blancco Diagnostics (India) Private Limited is headquartered at Sairadhe Complex,B Wing,Ofc No.109,Urbanwrk Floor5 Sangamwadi, Kennedy Rd, Bhd Hotel Sherat, On Grand, Pune, Maharashtra, 411001.

When was Blancco Diagnostics (India) Private Limited incorporated?

Blancco Diagnostics (India) Private Limited was incorporated on 21 April 2016.

Who are the current directors of Blancco Diagnostics (India) Private Limited?

The current directors of Blancco Diagnostics (India) Private Limited are

What is the primary industry of Blancco Diagnostics (India) Private Limited?

The primary industry of Blancco Diagnostics (India) Private Limited is Information And Communication.

Is Blancco Diagnostics (India) Private Limited a listed company?

Blancco Diagnostics (India) Private Limited is unlisted.

What is the capital structure of Blancco Diagnostics (India) Private Limited?

The authorized capital of Blancco Diagnostics (India) Private Limited is ₹0.10 M, and the paid-up capital is ₹10.00 K .

What is the compliance status of Blancco Diagnostics (India) Private Limited?

The compliance status of Blancco Diagnostics (India) Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available